Nicholas Osborne (Jill P Smith)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Venues

International journal of molecular sciences

American journal of physiology. Gastrointestinal and liver physiology

Pancreas

Cancers

Georgetown University School of Medicine

University of Florida (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Georgetown University School of Medicine

United States

Professor :: Medicine

Pennsylvania State University College of Medicine

United States

Professor Emeritus :: Internal Medicine /GI

National Institutes of Health

United States

Director, Clinical & Translational Research :: NIDDK

Pennsylvania State University College of Medicine

United States

Full Professor :: Internal Medicine / GI

Pennsylvania State University College of Medicine

United States

Associate Professor with TENURE :: Internal Medicine /GI

Pennsylvania State University College of Medicine

United States

Assistant Professor :: Internal Medicine / GI

Education History

University of Florida

United States

BSC

Publications

Martha D Gay, Jack C Drda, Wenqiang Chen, Yimeng Huang, Amal A Yassin, Tetyana Duka, Hongbin Fang, Narayan Shivapurkar, Nicholas Osborne
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis. American journal of physiology. Gastrointestinal and liver physiology 326 (3) (2024)
Martha D Gay, Jack C Drda, Wenqiang Chen, Yimeng Huang, Amal A Yassin, Tetyana Duka, Hongbin Fang, Narayan Shivapurkar, Nicholas Osborne
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis. American journal of physiology. Gastrointestinal and liver physiology 326 (3) (2024)
Victor Ciofoaia, Wenqiang Chen, Bakain W Tarek, Martha Gay, Narayan Shivapurkar, Nicholas Osborne
The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial. Pharmaceutics 16 (5) (2024)
Victor Ciofoaia, Wenqiang Chen, Bakain W Tarek, Martha Gay, Narayan Shivapurkar, Nicholas Osborne
The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial. Pharmaceutics 16 (5) (2024)
Martha D Gay, Jack C Drda, Wenqiang Chen, Yimeng Huang, Amal A Yassin, Tetyana Duka, Hongbin Fang, Narayan Shivapurkar, Nicholas Osborne
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis. American journal of physiology. Gastrointestinal and liver physiology 326 (3) (2024)
Martha D Gay, Jack C Drda, Wenqiang Chen, Yimeng Huang, Amal A Yassin, Tetyana Duka, Hongbin Fang, Narayan Shivapurkar, Nicholas Osborne
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis. American journal of physiology. Gastrointestinal and liver physiology 326 (3) (2024)
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar, Hong Cao, Tetyana Duka, Bhaskar Kallakury, Sona Vasudevan, Nicholas Osborne
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. International journal of molecular sciences 24 (4) (2023)
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar, Hong Cao, Tetyana Duka, Bhaskar Kallakury, Sona Vasudevan, Nicholas Osborne
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. International journal of molecular sciences 24 (4) (2023)
Matthew A Huber, Sandeep Nadella, Hong Cao, Bhaskar Kallakury, Robin D Tucker, Martha D Gay, Narayan Shivapurkar, Elijah F Edmondson, Yuanzhen Yue, Wenyu Dou, Hong-Bin Fang, Nicholas Osborne
Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer? Pancreas 51 (9) (2023)
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar, Hong Cao, Tetyana Duka, Bhaskar Kallakury, Sona Vasudevan, Nicholas Osborne
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. International journal of molecular sciences 24 (4) (2023)
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar, Hong Cao, Tetyana Duka, Bhaskar Kallakury, Sona Vasudevan, Nicholas Osborne
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. International journal of molecular sciences 24 (4) (2023)
Matthew A Huber, Sandeep Nadella, Hong Cao, Bhaskar Kallakury, Robin D Tucker, Martha D Gay, Narayan Shivapurkar, Elijah F Edmondson, Yuanzhen Yue, Wenyu Dou, Hong-Bin Fang, Nicholas Osborne
Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer? Pancreas 51 (9) (2023)
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar, Hong Cao, Tetyana Duka, Bhaskar Kallakury, Sona Vasudevan, Nicholas Osborne
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. International journal of molecular sciences 24 (4) (2023)
Gurbani Jolly, Tetyana Duka, Narayan Shivapurkar, Wenqiang Chen, Sunil Bansal, Amrita K Cheema, Nicholas Osborne
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic. Cancers 15 (10) (2023)
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar, Hong Cao, Tetyana Duka, Bhaskar Kallakury, Sona Vasudevan, Nicholas Osborne
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. International journal of molecular sciences 24 (4) (2023)
Nicholas Osborne, Wenqiang Chen, Narayan Shivapurkar, Monica Gerber, Robin D Tucker, Bhaskar Kallakury, Siva Sai Krishna Dasa, Ruvanthi N Kularatne, Stephan T Stern
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression. International journal of molecular sciences 24 (1) (2023)
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar, Hong Cao, Tetyana Duka, Bhaskar Kallakury, Sona Vasudevan, Nicholas Osborne
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. International journal of molecular sciences 24 (4) (2023)
Matthew A Huber, Sandeep Nadella, Hong Cao, Bhaskar Kallakury, Robin D Tucker, Martha D Gay, Narayan Shivapurkar, Elijah F Edmondson, Yuanzhen Yue, Wenyu Dou, Hong-Bin Fang, Nicholas Osborne
Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer? Pancreas 51 (9) (2023)
Nicholas Osborne, Wenqiang Chen, Narayan Shivapurkar, Monica Gerber, Robin D Tucker, Bhaskar Kallakury, Siva Sai Krishna Dasa, Ruvanthi N Kularatne, Stephan T Stern
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression. International journal of molecular sciences 24 (1) (2023)
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar, Hong Cao, Tetyana Duka, Bhaskar Kallakury, Sona Vasudevan, Nicholas Osborne
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. International journal of molecular sciences 24 (4) (2023)
Nicholas Osborne, Wenqiang Chen, Narayan Shivapurkar, Monica Gerber, Robin D Tucker, Bhaskar Kallakury, Siva Sai Krishna Dasa, Ruvanthi N Kularatne, Stephan T Stern
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression. International journal of molecular sciences 24 (1) (2023)
Matthew A Huber, Sandeep Nadella, Hong Cao, Bhaskar Kallakury, Robin D Tucker, Martha D Gay, Narayan Shivapurkar, Elijah F Edmondson, Yuanzhen Yue, Wenyu Dou, Hong-Bin Fang, Nicholas Osborne
Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer? Pancreas 51 (9) (2023)
Atoosa Rabiee, Martha D Gay, Narayan Shivapurkar, Hong Cao, Sandeep Nadella, Coleman I Smith, James H Lewis, Sunil Bansal, Amrita Cheema, John Kwagyan, Nicholas Osborne
Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic Steatohepatitis. Clinical pharmacology and therapeutics 112 (6) (2022)
Christine C Hsu, Sunil Bansal, Hong Cao, Coleman I Smith, Aiwu Ruth He, Martha D Gay, Yaoxiang Li, Amrita Cheema, Nicholas Osborne
Safety and Pharmacokinetic Assessment of Oral Proglumide in Those with Hepatic Impairment. Pharmaceutics 14 (3) (2022)
Martha D Gay, Hong Cao, Narayan Shivapurkar, Sivanesan Dakshanamurthy, Bhaskar Kallakury, Robin D Tucker, John Kwagyan, Nicholas Osborne
Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome. International journal of molecular sciences 23 (3) (2022)
Zoe X Malchiodi, Hong Cao, Martha D Gay, Anita Safronenka, Sunil Bansal, Robin D Tucker, Benjamin A Weinberg, Amrita Cheema, Narayan Shivapurkar, Nicholas Osborne
Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment. Cancers 13 (19) (2021)
Nicholas Osborne, Hong Cao, Elijah F Edmondson, Siva Sai Krishna Dasa, Stephan T Stern
Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas. Biomolecules 11 (12) (2021)
Meena U Rajagopal, Shivani Bansal, Prabhjit Kaur, Shreyans K Jain, Tatiana Altadil, Charles P Hinzman, Yaoxiang Li, Joanna Moulton, Baldev Singh, Sunil Bansal, Siddheshwar Kisan Chauthe, Rajbir Singh, Partha P Banerjee, Mark Mapstone, Massimo S Fiandaca, Howard J Federoff, Keith Unger, Nicholas Osborne, Amrita K Cheema
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC. Cancers 13 (24) (2021)
Robin D Tucker, Victor Ciofoaia, Sandeep Nadella, Martha D Gay, Hong Cao, Matthew Huber, Anita Safronenka, Narayan Shivapurkar, Bhaskar Kallakury, Annie J Kruger, Alexander H K Kroemer, Nicholas Osborne
A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma. Digestive diseases and sciences 65 (1) (2019)
Nicholas Osborne, Rebecca Sundseth, Martha D Gay, Hong Cao, Robin D Tucker, Sandeep Nadella, Shangzi Wang, Xunxian Liu, Alexander Kroemer, Lynda Sutton, Allen Cato, Nicholas Osborne
Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases. American journal of physiology. Gastrointestinal and liver physiology 317 (5) (2019)
Nicholas Osborne, Rebecca Sundseth, Julian Burks, Hong Cao, Xunxian Liu, Alexander H Kroemer, Lynda Sutton, Allen Cato, Jill P Smith
Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment. Cancer immunology, immunotherapy : CII 68 (10) (2019)
Sandeep Nadella, Victor Ciofoaia, Hong Cao, Bhaskar Kallakury, Robin D Tucker, Nicholas Osborne
Cholecystokinin Receptor Antagonist Therapy Decreases Inflammation and Fibrosis in Chronic Pancreatitis. Digestive diseases and sciences 65 (5) (2019)
Sandeep Nadella, Julian Burks, Abdulhameed Al-Sabban, Gloria Inyang, Juan Wang, Robin D Tucker, Marie E Zamanis, William Bukowski, Narayan Shivapurkar, Nicholas Osborne
Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor. American journal of physiology. Gastrointestinal and liver physiology 315 (5) (2018)

Nicholas Osborne.css-eqlu8i{font-size:small;padding-left:4px;} (Jill P Smith)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas Osborne (Jill P Smith)